The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
As participações na receita são estimativas para six months ended July 3, 2026, não números de um relatório oficial.
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Demonstrações financeiras completas →
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
Construído a partir dos próprios documentos de Envista Holdings Corporation entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
NVST · NYSE · Healthcare · Medical Instruments and Supplies
US$ 24,66-2,5%fechamento 12 de nov.
Números até 2 de outubro de 2026, do 10-Q arquivado em 4 de novembro de 2026
Envista makes dental implants, orthodontic braces and clear aligners, dental imaging equipment and software, and materials used in dental care.
Just reported
From Envista's results release of 4 de novembro de 2026; its quarterly report has since been filed.
Actual
US$ 691,5M
+3,2% y/y
-5,3% q/q
Guided
—
No guide given
Actual
US$ 3,11
Guided
—
No guide given
EPS, adjusted: US$ 0,40
Actual
US$ 515,2M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
A faixa sob o preço mostra a nota em cada data, calculada só com os documentos já públicos naquele momento.
Mostrando 2 de 28 trimestres do histórico de notas de Envista Holdings Corporation. Os outros 26 vão até fevereiro de 2020.